Approval · Notice of Compliance 7997 · 2006
AMEVIVE: Notice of Compliance 7997
Issued June 1, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7997
- Date
- June 1, 2006
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Selective immunomodulating antipsoriatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMEVIVE | 02258986 | — |
| AMEVIVE | 02259052 | Cancelled Post Market |